Viridian Therapeutics, Inc. VRDN Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s change in AP?
- Viridian Therapeutics, Inc. (VRDN) reported change in AP of $4.63M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s change in AP changed year-over-year?
- Viridian Therapeutics, Inc.'s change in AP increased by 162.3% year-over-year, from $1.77M to $4.63M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s change in AP?
- Over 2 years (2022 to 2024), Viridian Therapeutics, Inc.'s change in AP has grown at a -92.0% compound annual growth rate (CAGR), from $11.52M to -$73K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.